BioNTech SE (BNTX) Cash from Operations (2018 - 2025)
BioNTech SE's Cash from Operations history spans 8 years, with the latest figure at 360271467.8 for Q4 2025.
- On a quarterly basis, Cash from Operations rose 172.77% to 360271467.8 in Q4 2025 year-over-year; TTM through Dec 2025 was 796296501.11, a 56.44% decrease, with the full-year FY2025 number at 515193902.59, up 132.12% from a year prior.
- Cash from Operations hit 360271467.8 in Q4 2025 for BioNTech SE, up from 821206181.94 in the prior quarter.
- Over the last five years, Cash from Operations for BNTX hit a ceiling of 4818442194.59 in Q3 2022 and a floor of 821206181.94 in Q1 2025.
- Historically, Cash from Operations has averaged 1136509610.56 across 5 years, with a median of 610745208.3 in 2021.
- Biggest five-year swings in Cash from Operations: soared 3362.17% in 2022 and later crashed 154.08% in 2024.
- Tracing BNTX's Cash from Operations over 5 years: stood at 228222204.75 in 2021, then skyrocketed by 470.69% to 845989115.3 in 2022, then grew by 8.22% to 915517268.55 in 2023, then tumbled by 154.08% to 495080248.9 in 2024, then soared by 172.77% to 360271467.8 in 2025.
- Business Quant data shows Cash from Operations for BNTX at 360271467.8 in Q4 2025, 821206181.94 in Q1 2025, and 495080248.9 in Q4 2024.